Bora Pharmaceuticals Co., LTD. (TPE:6472)

Market Cap	77.08B
Revenue (ttm)	21.32B
Net Income (ttm)	4.15B
Shares Out	124.12M
EPS (ttm)	30.86
PE Ratio	16.41
Forward PE	16.19
Dividend	11.67 (1.88%)
Ex-Dividend Date	Jun 20, 2025

Volume	750,307
Average Volume	747,676
Open	621.00
Previous Close	621.00
Day's Range	612.00 - 625.00
52-Week Range	468.72 - 795.00
Beta	0.68
RSI	32.00
Earnings Date	Nov 12, 2025

About TPE:6472

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibioti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 36
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, TPE:6472's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.